Skip to content

Peer-led Community-based PrEP Delivery Among Youth in Brazil

Determining the Impact of Peer-led Community-based PrEP Delivery Among Youth in Brazil: A Randomized Controlled Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06661356
Acronym
COMPrEP
Enrollment
1400
Registered
2024-10-28
Start date
2026-10-01
Completion date
2029-08-01
Last updated
2026-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV, Pre-Exposure Prophylaxis (PrEP)

Keywords

PrEP, Pre-Exposure Prophylaxis, HIV, Peer lay workers, Youth

Brief summary

The goal of this project is to conduct a series of studies to refine, test, and understand experiences with a peer-led community-based intervention in which youth will be integrated into health care teams and trained to deliver HIV pre-exposure prophylaxis (PrEP) to their peers. The study team will conduct a randomized trial to determine if peer delivery of PrEP to youth aged 15-24 in Brazil will increase PrEP uptake, persistence, and adherence compared to standard PrEP care provided in health facilities.

Detailed description

HIV is declining in many parts of the world, but rising in Latin America, including Brazil. The HIV epidemic in Brazil, including the number of new infections, is concentrated among youth aged 15-24. Youth in Brazil face obstacles to HIV prevention. Use of HIV pre-exposure prophylaxis (PrEP) lags far behind PrEP need in Brazil. There is international momentum to promote PrEP as prevention and to increase access to low barrier care. Peer lay workers are a promising approach to address the unmet need for PrEP uptake and adherence among youth in Brazil. COMPrEP is a multi-site randomized controlled trial designed to determine if peer delivery of PrEP to youth aged 15-24 in Brazil will increase PrEP uptake, persistence, and adherence compared to standard PrEP care provided in affirming health facilities. Eligible youth (N=1400) in two municipalities in Brazil (i.e., Salvador and São Paulo) will be randomized to 1:1 to either the COMPrEP intervention arm (PrEP access through peer lay workers in community venues) or the standard care arm (PrEP access through health providers at health facilities). It is anticipated that approximately 245 and 140 youth will initiate PrEP in intervention and standard care arms, respectively, and these will be followed for 12 months, facilitating measurement of PrEP adherence and persistence outcomes on this subset.

Interventions

BEHAVIORALCOMPrEP

Participants will be paired with peer lay workers and will meet with peer lay workers at private community location. They will discuss options for oral PrEP with peer lay workers and be provided provide daily oral PrEP or event-driven (2-1-1) PrEP. Participants will take part in rapid HIV testing at each visit. They will also meet with peer lay workers at private community location for follow-up at 1, 5, 9, and 13 months.

Sponsors

University of Alabama at Birmingham
Lead SponsorOTHER
National Institute of Mental Health (NIMH)
CollaboratorNIH
University of Sao Paulo
CollaboratorOTHER
Federal University of Bahia
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Masking description

Blinding will not be possible for participants, peer lay workers, and health providers, but the data management and analysis teams will be blinded to the study arm.

Eligibility

Sex/Gender
ALL
Age
15 Years to 24 Years
Healthy volunteers
Yes

Inclusion criteria

Eligibility Criteria: * Aged 15-24 years * Candidate for HIV prevention * Sexually active * Not currently using PrEP * Willing to discuss oral PrEP * Agree to be randomized to either intervention or standard care arm

Exclusion criteria

* HIV positive test result * Not currently sexually active * Currently using PrEP

Design outcomes

Primary

MeasureTime frameDescription
PrEP UptakeWithin 1 month of enrollmentReceived at least one PrEP prescription

Secondary

MeasureTime frameDescription
PrEP Adherence Self-ReportAt 1, 5, 9, and 13 monthsNumber of pills taken in the past 30 days
PrEP Persistence5 months and 13 monthsContinuing to take PrEP at 5 months and 13 months
PrEP Adherence Biomarker1 monthPositive point of care urine tenofovir assay

Countries

Brazil

Contacts

CONTACTKatia J Bruxvoort, PhD
kbruxvoort@uab.edu(205) 975-8625
CONTACTMallie E Froehlich, MSW
mefroehl@uab.edu205-478-1102
PRINCIPAL_INVESTIGATORKatia J Bruxvoort, PhD

University of Alabama at Birmingham School of Public Health

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026